BSc (Hons), MSc, MBPsS
Clinical Research Facilitator
I am currently responsible for the management of PACE Oxford and RIVET. I am also supporting the INVICTUS trial team.
PACE is a randomised controlled trial that aims to evaluate whether using a CRP point of care test (POCT) results in better targeting of antibiotic treatment than usual care informed by NICE and GOLD guidelines. The primary outcomes are the overall consumption of antibiotics for COPD and patient-rated clinical recovery from their acute exacerbations, with the aim being to reduce overall antibiotic use without compromising patient recovery.
The sponsor is the University of Cardiff. The Oxford University Primary Care Clinical Trials Unit is a coordinating center.
RIVET is a pilot study aiming to examine the feasibility and acceptability of the baseline and follow-up processes of INVICTUS; a large scale vaccine trial the Primary Care Clinical Trials Unit will be running next year.
The sponsor is Vaccitech.
INVICTUS is a large scale Phase II trial aiming to determine the safety and efficacy of a new flu vaccine in combination with the seasonal flu vaccine in adults 65 years and older.
The study is run in collaboration with the Jenner Institute and Vaccitech, who is the sponsor.
I have previously worked on:
ATAFUTI: investigating alternative treatments to antibiotics in adult women with suspected UTI.
ALIC4E-Oxford: examining the use of antivirals for flu-like illness as a clinical and cost effective treatment (compared to current best practice).
TOAST: investigating treatment options without antibiotics for sore throat.
Prior to my current position:
I have worked as an assistant project manager at the Diabetes Trials Unit (OCDEM) on a multinational secondary care trial (EXSCEL).
I have also worked as a research assistant at the Health Experiences Research Group (HERG) on projects related to young people's experiences with primary care, patients' experiences with chronic kidney disease, cancer, diabetes and shoulder and knee replacement surgery.